CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from An

StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance Shares of CASI Pharmaceuticals stock opened at $3.11 on Friday. CASI Pharmaceuticals has a one year low of $1.85 and […]

Related Keywords

United States , , Pharmaceuticals Inc , Virtu Financial , Pharmaceuticals Daily , Pharmaceuticals Stock Performance , Susquehanna International Group , Citigroup Inc , Renaissance Technologies , Pharmaceuticals Company Profile , Free Report , International Group , Get Free Report , Casi Pharmaceuticals , Nasdaq Casi , Casi , Medical , Initiated Coverage , Stocknews Com ,